ZA88317B - New 11-aryl steroid derivatives - Google Patents

New 11-aryl steroid derivatives

Info

Publication number
ZA88317B
ZA88317B ZA880317A ZA88317A ZA88317B ZA 88317 B ZA88317 B ZA 88317B ZA 880317 A ZA880317 A ZA 880317A ZA 88317 A ZA88317 A ZA 88317A ZA 88317 B ZA88317 B ZA 88317B
Authority
ZA
South Africa
Prior art keywords
carbon atoms
group
hydrocarbon
oxo
saturated
Prior art date
Application number
ZA880317A
Other languages
English (en)
Inventor
Jan Jozef Loozen Hubert
Original Assignee
Akzo N.V.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Akzo N.V. filed Critical Akzo N.V.
Publication of ZA88317B publication Critical patent/ZA88317B/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J1/00—Normal steroids containing carbon, hydrogen, halogen or oxygen, not substituted in position 17 beta by a carbon atom, e.g. estrane, androstane
    • C07J1/0051—Estrane derivatives
    • C07J1/0059—Estrane derivatives substituted in position 17 by a keto group
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J41/00—Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J1/00—Normal steroids containing carbon, hydrogen, halogen or oxygen, not substituted in position 17 beta by a carbon atom, e.g. estrane, androstane
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J1/00—Normal steroids containing carbon, hydrogen, halogen or oxygen, not substituted in position 17 beta by a carbon atom, e.g. estrane, androstane
    • C07J1/0051—Estrane derivatives
    • C07J1/0066—Estrane derivatives substituted in position 17 beta not substituted in position 17 alfa
    • C07J1/007—Estrane derivatives substituted in position 17 beta not substituted in position 17 alfa the substituent being an OH group free esterified or etherified
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J1/00—Normal steroids containing carbon, hydrogen, halogen or oxygen, not substituted in position 17 beta by a carbon atom, e.g. estrane, androstane
    • C07J1/0051—Estrane derivatives
    • C07J1/0081—Substituted in position 17 alfa and 17 beta
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J21/00—Normal steroids containing carbon, hydrogen, halogen or oxygen having an oxygen-containing hetero ring spiro-condensed with the cyclopenta(a)hydrophenanthrene skeleton
    • C07J21/001—Lactones
    • C07J21/003—Lactones at position 17
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J21/00—Normal steroids containing carbon, hydrogen, halogen or oxygen having an oxygen-containing hetero ring spiro-condensed with the cyclopenta(a)hydrophenanthrene skeleton
    • C07J21/005—Ketals
    • C07J21/006—Ketals at position 3
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J41/00—Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring
    • C07J41/0033—Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring not covered by C07J41/0005
    • C07J41/0077—Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring not covered by C07J41/0005 substituted in position 11-beta by a carbon atom, further substituted by a group comprising at least one further carbon atom
    • C07J41/0083—Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring not covered by C07J41/0005 substituted in position 11-beta by a carbon atom, further substituted by a group comprising at least one further carbon atom substituted in position 11-beta by an optionally substituted phenyl group not further condensed with other rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J71/00—Steroids in which the cyclopenta(a)hydrophenanthrene skeleton is condensed with a heterocyclic ring
    • C07J71/0005—Oxygen-containing hetero ring
    • C07J71/001—Oxiranes

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Steroid Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
ZA880317A 1987-01-23 1988-01-18 New 11-aryl steroid derivatives ZA88317B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
NL8700157 1987-01-23

Publications (1)

Publication Number Publication Date
ZA88317B true ZA88317B (en) 1988-07-27

Family

ID=19849457

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA880317A ZA88317B (en) 1987-01-23 1988-01-18 New 11-aryl steroid derivatives

Country Status (16)

Country Link
EP (1) EP0277676B1 (ja)
JP (1) JP2664390B2 (ja)
KR (1) KR960013448B1 (ja)
CN (1) CN1030081C (ja)
AT (1) ATE73137T1 (ja)
AU (1) AU603637B2 (ja)
CA (1) CA1339570C (ja)
DE (1) DE3868647D1 (ja)
DK (1) DK163307C (ja)
ES (1) ES2031991T3 (ja)
FI (1) FI89054C (ja)
GR (1) GR3004783T3 (ja)
IE (1) IE60780B1 (ja)
NZ (1) NZ223262A (ja)
PT (1) PT86602B (ja)
ZA (1) ZA88317B (ja)

Families Citing this family (32)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BE1004905A4 (fr) * 1987-12-30 1993-02-23 Roussel Uclaf Nouveaux derives 17beta-oh 19-nor steroides substitues en 17alpha, leur procede de preparation, leur application comme medicaments et les compositions pharmaceutiques les renfermant.
US4954490A (en) * 1988-06-23 1990-09-04 Research Triangle Institute 11 β-substituted progesterone analogs
DE3832303A1 (de) * 1988-09-20 1990-04-12 Schering Ag 11ss-phenyl-14ssh-steroide
US5364847A (en) * 1989-03-10 1994-11-15 Endorecherche Inhibitors of sex steroid biosynthesis and methods for their production and use
US5372996A (en) * 1989-03-10 1994-12-13 Endorecherche, Inc. Method of treatment of androgen-related diseases
CA2062792C (en) * 1989-07-07 2006-03-21 Fernard Labrie Treatment of androgen-related diseases
EP0485392B1 (en) * 1989-07-07 1998-09-09 Endorecherche Inc. Androgen derivatives for use in the inhibition of sex steroid activity
EP0411733B1 (de) * 1989-08-04 1998-10-21 Schering Aktiengesellschaft 11 Beta-Aryl-gona-4,9-dien-3-one
FR2650748B1 (fr) * 1989-08-08 1991-11-08 Roussel Uclaf Nouveaux esters d'acides organiques avec des alcools derives de 19-nor steroides et leurs sels, leur procede de preparation et les intermediaires de ce procede, leur application a titre de medicaments et les compositions les renfermant
DE4018167A1 (de) * 1990-06-01 1991-12-05 Schering Ag Verfahren zur herstellung von 10(beta)-h-steroiden
US5407928A (en) * 1990-08-15 1995-04-18 Schering Aktiengesellschaft 11β-aryl-gona-4,9-dien-3-ones
ZA929315B (en) * 1991-12-20 1993-05-24 Akzo Nv 17-spirofuran-3'-ylidene steroids.
KR950701527A (ko) * 1992-05-21 1995-04-28 라브리 페르낭 테스토스테론 5α 환원효소 활성 저해제(INHIBITORS OF TESTOSTERONE 5α-REDUCTASE ACTIVITY)
AU680818B2 (en) * 1992-05-21 1997-08-14 Endorecherche Inc. Improved antiandrogens
JPH09501408A (ja) * 1993-06-15 1997-02-10 フェリン コーポレイション ヒト視床下部機能における変化の神経化学的イニシエータとしてのエストレンステロイドおよび関連する薬理組成物並びに方法
DE4415590A1 (de) * 1994-04-28 1995-11-02 Schering Ag Verfahren zur stereoselektiven Einführung einer Alkinylseitenkette an 11ß-Aryl-substituierten 13alpha-Alkylgonan-17-onen
ZA9510926B (en) 1994-12-23 1996-07-03 Schering Ag Compounds with progesterone-antagonistic and antiestrogenic action to be used together for female contraception
US6020328A (en) * 1998-03-06 2000-02-01 Research Triangle Institute 20-keto-11β-arylsteroids and their derivatives having agonist or antagonist hormonal properties
US6262042B1 (en) 1998-05-29 2001-07-17 Research Triangle Institute 17β-amino and hydroxylamino-11β-arylsteroids and their derivatives having agonist or antagonist hormonal properties
US5962444A (en) * 1998-05-29 1999-10-05 Research Triangle Institute 17β-nitro-11β-arylsteroids and their derivatives having agonist or antagonist hormonal properties
ATE228143T1 (de) 1999-03-08 2002-12-15 Akzo Nobel Nv 14.beta.,17-alpha-hydroxymethylandrostan derivate als androgene
KR100730010B1 (ko) * 1999-12-02 2007-06-20 엔.브이.오가논 신규 안드로겐
HUP0203611A3 (en) 1999-12-02 2004-07-28 Akzo Nobel Nv 14,15-beta-methylene substituted androgens and their use for preparation of the medicaments
TW200531977A (en) 2004-03-25 2005-10-01 Akzo Nobel Nv Progesterone receptor modulators
EP2582713A1 (en) 2010-06-17 2013-04-24 MSD Oss B.V. (11 beta,17 alpha)-11-(4-(2-11c-acetyl)phenyl)-17,23-epoxy-19,24-dinorchola-4,9,20-trien-3-one
EA025511B1 (ru) * 2011-06-01 2016-12-30 Эстетра С.П.Р.Л. Способ получения промежуточных соединений эстетрола
CN107266514A (zh) 2011-06-01 2017-10-20 埃斯特拉私人有限责任公司 用于产生雌四醇中间体的方法
EP2383279A1 (en) 2011-07-19 2011-11-02 Pantarhei Bioscience B.V. Process for the preparation of estetrol
CN113559075A (zh) 2014-11-17 2021-10-29 康泰科思特生物制药公司 奥那司酮延长释放组合物和方法
MX2018007154A (es) 2015-12-15 2019-01-10 Context Biopharma Inc Composiciones de onapristona amorfa y metodos para hacer las mismas.
US20180148471A1 (en) 2016-11-30 2018-05-31 Arno Therapeutics, Inc. Methods for onapristone synthesis dehydration and deprotection
CN110437294A (zh) * 2019-07-21 2019-11-12 浙江神洲药业有限公司 一种制备群勃龙醋酸酯的方法

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ZA8231B (en) * 1981-01-09 1982-11-24 Roussel Uclaf New 11 -substituted steroid derivatives, their preparation, their use as medicaments, the compositions containing them and the new intermediates thus obtained
ES8502612A1 (es) * 1983-06-15 1985-02-01 Schering Ag Procedimiento para la preparacion de 13a-alquilgonanos

Also Published As

Publication number Publication date
PT86602A (pt) 1988-02-01
CA1339570C (en) 1997-12-09
DK30488D0 (da) 1988-01-22
DK30488A (da) 1988-07-24
DE3868647D1 (de) 1992-04-09
FI89054B (fi) 1993-04-30
FI880257A (fi) 1988-07-24
FI880257A0 (fi) 1988-01-21
IE880103L (en) 1988-07-23
DK163307C (da) 1992-07-06
FI89054C (fi) 1993-08-10
CN1030081C (zh) 1995-10-18
NZ223262A (en) 1989-08-29
AU603637B2 (en) 1990-11-22
AU1066988A (en) 1988-07-28
DK163307B (da) 1992-02-17
KR880009036A (ko) 1988-09-13
EP0277676B1 (en) 1992-03-04
PT86602B (pt) 1991-12-31
IE60780B1 (en) 1994-08-10
JP2664390B2 (ja) 1997-10-15
GR3004783T3 (ja) 1993-04-28
ATE73137T1 (de) 1992-03-15
JPS63216895A (ja) 1988-09-09
KR960013448B1 (ko) 1996-10-05
CN88100979A (zh) 1988-08-17
ES2031991T3 (es) 1993-01-01
EP0277676A1 (en) 1988-08-10

Similar Documents

Publication Publication Date Title
ZA88317B (en) New 11-aryl steroid derivatives
ES474288A1 (es) Un procedimiento para la preparacion de derivados del acido 7-oxo-1-aza-biciclo-(3,2,0)-hept-2-en-carboxilico 3 y 6-sus-tituidos
ES8308314A1 (es) Procedimiento para preparar derivados de 2-amino-4-hidroxiquinazolina.
ES2053714T3 (es) Proceso para la preparacion de 11-arilesteroides.
NZ224355A (en) Derivatives of 11-(aminophenyl)-oestra-4,9-diene-3-one and 11-(aminophenyl)-pregna-4,9-diene-3-one and pharmaceutical compositions
EP0308145A3 (en) Mylbemycin derivatives with antiparasitic activity
ES8205224A1 (es) Un procedimiento para la preparacion de acidos 1-carbadetiapen-2-em-3-carboxilios 6-1-y 2-sustituidos.
DE3266922D1 (en) At position 17 esterified and at position 21 thio-esterified steroids, process for their preparation and their utilisation as pharmaceutical preparations
IE812843L (en) Estra-4,9-dienes
GB1435481A (en) Process for isolation of dipeptide esters
ES8106281A1 (es) Procedimiento para la obtencion de derivados de los acidos aminosulfonicos
JPS5441849A (en) Novel cyclopentane derivative